Osaka, Japan

Takaya Sugiura

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Osaka University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaya Sugiura. Retrieved from https://idiyas.com/inventor/takaya-sugiura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takaya Sugiura: Innovator in Nucleoside and Nucleotide Research

Introduction

Takaya Sugiura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of nucleoside and nucleotide research. His innovative work has led to the development of a unique 5′-modified nucleoside that has potential applications in various industries.

Latest Patents

Takaya Sugiura holds a patent for a 5′-modified nucleoside and nucleotide. This invention is represented by the formula (I) and provides a substitute for phosphorothioate-modified nucleic acids, which can accumulate in specific organs. The 5′-modified nucleoside boasts excellent industrial productivity, as it does not require a diastereomer separation step in its production process. He has 1 patent to his name.

Career Highlights

Sugiura is affiliated with Osaka University, where he continues to advance his research in nucleoside and nucleotide applications. His work is recognized for its potential to improve the safety and efficacy of nucleic acid-based therapies.

Collaborations

He has collaborated with notable colleagues, including Satoshi Obika and Takao Yamaguchi, to further enhance the impact of his research.

Conclusion

Takaya Sugiura's innovative contributions to nucleoside and nucleotide research highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has practical implications for future applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…